Dr. Rodriguez is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
8116 Vailview Cove
Austin, TX 78750- Is this information wrong?
Education & Training
- Baylor College of MedicinePost-Doctoral Fellowship, Komen for the Cure Multidisciplinary Breast Cancer Fellowship, 2007 - 2009
- Baylor College of MedicineFellowship, Hematology and Medical Oncology, 2005 - 2008
- Baylor College of MedicineResidency, Internal Medicine, 2002 - 2005
- Universidad Central del Caribe School of MedicineClass of 2002
Certifications & Licensure
- TX State Medical License 2004 - 2024
Clinical Trials
- S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer Start of enrollment: 2011 Nov 01
- Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer Start of enrollment: 2011 Jan 15
- PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score Start of enrollment: 2012 May 01
- Join now to see all
Publications & Presentations
PubMed
- 5 citationsTreatment Response Monitoring Using a Tumor-Informed Circulating Tumor DNA Test in an Advanced Triple-Negative Breast Cancer Patient: A Case Report.Georges Azzi, Shifra Krinshpun, Antony Tin, Minu Maninder, Allyson Koyen Malashevich, Meenakshi Malhotra, Ruben Ruiz Vega, Paul R Billings, Angel Rodriguez, Alexey Ale...> ;Case Reports in Oncology. 2022 May 2
- 30 citationsImpact of Circulating Tumor DNA-Based Detection of Molecular Residual Disease on the Conduct and Design of Clinical Trials for Solid Tumors.Pashtoon M Kasi, Gordon Fehringer, Hiroya Taniguchi, Naureen Starling, Yoshiaki Nakamura, Daisuke Kotani, Thomas Powles, Bob T Li, Lajos Pusztai, Vasily N Aushev, Ekat...> ;JCO Precision Oncology. 2022 Mar 1
- 39 citationsA phase 1/2 clinical trial of the nitric oxide synthase inhibitor L-NMMA and taxane for treating chemoresistant triple-negative breast cancer.Andrew W Chung, Kartik Anand, Ann C Anselme, Alfred A Chan, Nakul Gupta, Luz A Venta, Mary R Schwartz, Wei Qian, Yitian Xu, Licheng Zhang, John Kuhn, Tejal Patel, Ange...> ;Science Translational Medicine. 2021 Dec 15
- Join now to see all
Press Mentions
- Catching Cancer Red-HandedDecember 1st, 2021
- Drug That Improves Blood Flow in Damaged Heart Might Also Fight Breast CancerJanuary 6th, 2017
Hospital Affiliations
- Ascension Seton Medical Center AustinAustin, Texas
- St. David's Medical CenterAustin, Texas
- Kindred Hospital Houston Medical CenterHouston, Texas
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: